SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-024972
Filing Date
2010-02-09
Accepted
2010-02-09 06:05:33
Documents
3
Period of Report
2010-02-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17831
2 PRESS RELEASE dex991.htm EX-99.1 7331
3 GRAPHIC g96725g65a50.jpg GRAPHIC 12632
  Complete submission text file 0001193125-10-024972.txt   44256
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 10582325
SIC: 2834 Pharmaceutical Preparations